Article
Metabolic and behavioral effects of neurofibromin result from differential recruitment of MAPK and mTOR signaling
2025-07-30
Abstract excerpt
Neurofibromatosis type 1 results from mutations in the Neurofibromin 1 gene and its encoded neurofibromin protein. This condition produces multiple symptoms, including tumors, behavioral alterations, and metabolic changes. Molecularly, neu-rofibromin mutations affect Ras activity, influencing multiple downstream signaling pathways, including MAPK (Raf/MEK/ERK) and PI3K/Akt/mTOR signaling. This pleiotropy raises t...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1b05ec7f-8192-54bf-ac17-02756ff331ba
- DOI
- 10.1101/2025.07.25.666841
